14:20 IST
BSE
Management Change
Johnson Pharmacare Management Change
Company Secretary Neha Srivastava resigned from the board effective June 11, 2026. The board acknowledges the change with no other material impact.
Johnson Pharmacare Ltd
- Share price
- ₹0.42
- Market cap
- ₹23.10 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-55.73 Cr
- P/E (TTM)
- -0.4×Sector 40.0×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 4Management Change 4Financial Results 2Board Meeting Date 2Debt & Borrowing 1
Time
4 announcements with these filters
19:20 IST
BSE
Management Change
Johnson Pharmacare Management Change
Johnson Pharmacare Limited announced the resignations of Mr. Rajender Parsad (Non-Executive Director) and Mr. Umesh Kumar (Executive Director), effective April 17, 2026. Both directors cited personal reasons for their departures. The board took note of these changes during its meeting held on the same day.
18:55 IST
BSE
Management Change
Johnson Pharmacare Management Change
Johnson Pharmacare Ltd has appointed Mr. Nand Kishore Ray as an Additional Non-Executive & Non-Independent Director and Mr. Dheeraj Kumar as an Additional Executive Director, effective April 17, 2026. These appointments were approved during a Board of Directors meeting to strengthen the company's leadership team.
18:08 IST
BSE
Management Change
Johnson Pharmacare Management Change
Johnson Pharmacare Limited announced a board reorganization effective April 17, 2026. The company appointed Mr. Nand Kishore Ray and Mr. Dheeraj Kumar as Additional Directors. Simultaneously, Mr. Rajender Parsad and Mr. Umesh Kumar resigned from their respective directorships due to personal reasons. These changes represent a significant update to the company's senior leadership.